Brought to you by 
Abbott acquires Alza in $7.3bn stock swap; withdrawn
17 Dec 1999
Executive Summary
Abbott Laboratories has agreed to acquire pharmaceutical and drug delivery company Alza Corp. in a $7.3bn stock swap. The deal provides Alza stockholders with 1.2 Abbott common shares (selling at an average of $44.1 apiece the 10 days before announcement) for each Alza common share (about 135mm outstanding).
Deal Industry
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Withdrawn
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Abbott acquires Alza in $7.3bn stock swap; withdrawn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice